Skip to main content

Table 1 Baseline characteristics of identified subjects

From: Quantitative proteomics by iTRAQ-PRM based reveals the new characterization for gout

Items Control (N = 8) Acute Gout (N = 8) Gout Remission (N = 7) Asymptomatic Hyperuricemia (N = 7)
Male(n) 2 8 6 6
Age (year) 28.38 ± 1.97 50.13 ± 3.92* 44.57 ± 7.19 38.57 ± 6.34
Serum UA (μmol/L) 273.0 ± 19.90 550.3 ± 45.17*** 498.1 ± 55.78*** 509.2 ± 19.53***
SCr (μmol/L) 59.86 ± 5.60 86.44 ± 6.92 106.8 ± 19.84* 107.5 ± 12.09*
BUN (mmol/L) 4.49 ± 0.24 4.80 ± 0.41 5.40 ± 1.14 5.93 ± 0.53
TC (mmol/L) 4.81 ± 0.13 4.21 ± 0.31 4.00 ± 0.21 4.64 ± 0.39
TG (mmol/L) 0.74 ± 0.05 1.84 ± 0.37 1.80 ± 0.22 2.33 ± 0.67*
HDL-C (mmol/L) 1.80 ± 0.10 0.95 ± 0.075*** 0.98 ± 0.08*** 1.18 ± 0.14***
LDL-C (mmol/L) 2.42 ± 0.08 2.42 ± 0.25 2.28 ± 0.26 2.64 ± 0.38
Hypertension(n) 0 3 3 2
  1. Data present mean ± SD (minimum–maximum)
  2. UA Uric acid, SCr The serum level of creatinine, BUN Blood urea nitrogen, TC Total cholesterol, TG Total glycerides, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol
  3. P values were calculated by using χ2 test for gender, hypertension and one-way ANOVA test for others (*, p < 0.05; **, p < 0.01; ***, p < 0.001)